Get started
Author

Stuart Flanagan

The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agenda
2023 · Emily Martyn, Sarah Eisen, et al. · eLife · 86
Incorporating HIV /hepatitis B virus/hepatitis C virus combined testing into routine blood tests in nine UK Emergency Departments: the “Going Viral” campaign
2016 · C Orkin, S Flanagan, et al. · HIV Medicine · 65
Case finding and therapy for chronic viral hepatitis in primary care (HepFREE): a cluster-randomised controlled trial
2018 · Stuart Flanagan, Jan Kunkel, et al. · The Lancet. Gastroenterology & hepatology · 39
PDF
High prevalence of hepatitis C (HCV) in the emergency department (ED) of a London hospital: should we be screening for HCV in ED attendees?
2015 · C. ORKIN, E. LEACH, et al. · Epidemiology and Infection · 27
PDF
Peer support for people living with hepatitis B virus—A foundation for treatment expansion
2024 · Louise O. Downs, Kenneth Kabagambe, et al. · Journal of Viral Hepatitis · 22
PDF
Social, clinical and biological barriers to hepatitis B virus suppression with nucleos/tide analogue therapy: who is at risk and what should we do about it?
2024 · Yu Ri Im, Khadija Said Mohammed, et al. · Sexually Transmitted Infections · 19
PDF
Lopinavir and atazanavir in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery rates
2015 · MEO Perry, GP Taylor, et al. · HIV Medicine · 17
Elimination of hepatitis B requires recognition of catastrophic costs for patients and their families
2024 · Julie Jemutai, Louise Downs, et al. · The Lancet. Gastroenterology & hepatology · 13
PDF
Hepatitis B Virus: Infection, liver disease, carcinogen or syndemic threat? Remodelling the clinical and public health response
2022 · Philippa C. Matthews, Tongai Maponga, et al. · PLOS Global Public Health · 11
PDF
Simeprevir for the treatment of hepatitis C and HIV/hepatitis C co-infection
2014 · Stuart Flanagan, Andrew Crawford-Jones, et al. · Expert Review of Clinical Pharmacology · 11
Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practice
2025 · Flora Olcott, Philip D Oddie, et al. · Clinical Infectious Diseases · 10
The effect of tenofovir on renal function in HIV‐positive pregnant women
2014 · Stuart Flanagan, Lynne Barnes, et al. · Journal of the International AIDS Society · 9
PDF
Unifying the approach to tackling inequalities in liver health: learning from working with underserved populations
2024 · Kate Glyn-Owen, Ryan M Buchanan, et al. · The Lancet. Gastroenterology & hepatology · 6
Linkage to care after routine HIV, hepatitis B & C testing in the emergency department: the ‘Going Viral’ campaign
2016 · Rageshri Dhairyawan, Rebecca O'Connell, et al. · Sexually Transmitted Infections · 5
Current practice of periprocedural haematological management for patients undergoing image-guided procedures
2015 · J Kyaw Tun, S Khwaja, et al. · British Journal of Radiology · 5
Diagnosing and defining MASLD in people living with chronic hepatitis B
2026 · Emily Martyn, Alejandro Arenas-Pinto, et al. · Communications Medicine · 3
PDF
Multiple risk factors for persistent HBV viraemia in an adult receiving nucleos/tide analogue therapy
2024 · Sheila Lumley, Maeve Barlow, et al. · Sexually Transmitted Infections · 3
PDF
Extremely high HIV-1 viral load in a patient with undiagnosed clinical indicator disease for HIV infection
2015 · Stuart Flanagan, Sophia De Saram, et al. · BMJ Case Reports · 2
PDF
Varicella-zoster virus encephalitis mimicking toxoplasmosis relapse
2015 · Inês Brás Marques, Stuart Flanagan, et al. · Neurology Neuroimmunology & Neuroinflammation · 2
PDF
The interaction between chronic hepatitis B (CHB) and Metabolic dysfunction-associated steatotic liver disease (MASLD) in a diverse central London population
2026 · Emily Martyn, Claire Mullender, et al. · medRxiv · 1
PDF
Offering Hepatitis B vaccination to vulnerable populations: How can we plug the gaps?
2025 · Maeve Barlow, Stuart Flanagan, et al. · Vaccine · 1
TOP-268 Up to 2 years’ functional cure in response to bepirovirsen therapy in B-Clear Not-on-NA responders: B-Sure third report
2025 · Seng Gee Lim, Manuela Arbune, et al. · Journal of Hepatology · 1
HepFree: Screening migrant patients for viral hepatitis in primary care. A 90,000 patient randomised controlled trial indicates benefits are most obvious in older patients
2018 · S. Flanagan, V.J. Appleby, et al. · Journal of Hepatology · 1
Pneumocystis jirovecii
2017 · Stuart Flanagan · 1
P192 Pre-exposure prophylaxis for HIV prevention & hepatitis B treatment in people with hepatitis B: an opportunity for prevention, treatment and integrated care
2026 · Maeve Barlow, Agnes Kemper, et al. · Gut
Works count: 73
Citation count: 361
H-index: 10
I10-index: 11
Year
Topic
Type